Warning: Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
English Wikipedia
Nephropedia Template TP (
Twit Text
DeepDyve Pubget Overpricing |
lüll Dendritic cell-derived exosomes for cancer immunotherapy: what s next?Viaud S; Thery C; Ploix S; Tursz T; Lapierre V; Lantz O; Zitvogel L; Chaput NCancer Res 2010[Feb]; 70 (4): 1281-5Exosomes are nanovesicles originating from late endosomal compartments and secreted by most living cells in ex vivo cell culture conditions. The interest in exosomes was rekindled when B-cell and dendritic cell-derived exosomes were shown to mediate MHC-dependent immune responses. Despite limited understanding of exosome biogenesis and physiological relevance, accumulating evidence points to their bioactivity culminating in clinical applications in cancer. This review focuses on the preclinical studies exploiting the immunogenicity of dendritic cell-derived exosomes (Dex) and will elaborate on the past and future vaccination trials conducted using Dex strategy in melanoma and non-small cell lung cancer patients.|Animals[MESH]|Cancer Vaccines/therapeutic use[MESH]|Carcinoma, Non-Small-Cell Lung/immunology/therapy[MESH]|Clinical Trials as Topic/methods/trends[MESH]|Dendritic Cells/*cytology/ultrastructure[MESH]|Exosomes/immunology/*transplantation[MESH]|Humans[MESH]|Immunotherapy, Adoptive/*methods/trends[MESH]|Lung Neoplasms/immunology/therapy[MESH]|Models, Biological[MESH]|Neoplasms/immunology/*therapy[MESH] |